Alexis Rames

TL;DR: In this paper, the authors proposed a solid pharmaceutical dosage form for oral administration comprising a therapeutically active amount of bambuterol, or a pharmaceutically acceptable salt thereof, a therapeutic effective amount of N- (2-chloro-6-methylbenzoyl)-4-[(2,6-dichlorobenzoyl)amino]-L-phenylalanine-2- (diethylamino) ethyl ester, and one or more acceptable excipients.